ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

メトジラジン

Methdilazine

HCID 14677
ノート反応
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
1229-35-2
標準SMILES
CN1CCC(CN2c3ccccc3Sc3ccccc32)C1
InChIKey
HTMIBDQKFHUPSX-UHFFFAOYSA-N
分子式
C18H20N2S
平均分子量
296.4 g/mol
単同位体質量
296.13471982

概要

Crystals. (NTP, 1992)

名称と識別子

優先名称
Methdilazine
IUPAC
10-[(1-methylpyrrolidin-3-yl)methyl]phenothiazine
現地名
メトジラジン
英語名
METHDILAZINE (200 MG)
分子式
C18H20N2S
分子量
296.43

名称と別名

METHDILAZINETacaryl1982-37-2MethdilazinumTacazylMetodilazinaDilosynmetdilazinaNCI-C6072010-[(1-methylpyrrolidin-3-yl)methyl]-10H-phenothiazine4Q13LY9Z8X10-((1-Methyl-3-pyrrolidinyl)methyl)phenothiazine
名称をさらに表示
メトジラジン10-[(1-メチル-3-ピロリジニル)メチル]-10H-フェノチアジン10-[(1-メチルピロリジン-3-イル)メチル]-10H-フェノチアジン10-(1-メチル-3-ピロリジニルメチル)-10H-フェノチアジンC07175TacrylMJ 5022DisyncranDisyncram
CHEBI:6823DTXSID602328210-[(1-Methyl-3-Pyrrolidinyl)methyl]phenothiazinePhenothiazine, 10-((1-methyl-3-pyrrolidinyl)methyl)-Phenothiazine, 10-[(1-methyl-3-pyrrolidinyl)methyl]-10-((1-methylpyrrolidin-3-yl)methyl)-10H-phenothiazineRefChem:56651DTXCID903282

データベース識別子

CAS
1229-35-2、1982-37-2
PubChem CID
14677
DTXSID
DTXSID6023282
ChEMBL
CHEMBL1200959
ChEBI
CHEBI:6823

物性

構造計算による物性

XLogP
5.2
極性表面積
31.8 Ų
水素結合供与体数
0
水素結合受容体数
3
回転可能結合数
2
重原子数
21
形式電荷
0
複雑度
339

実験および物理化学的性質

LogP · 2 件

4.3

3.87

Solubility1.47e-02 g/L
Human Drugs · 2 件

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Melting Point · 3 件

189 to 190 °F (NTP, 1992)

87-88 °C

87 - 88 °C

Physical Description · 2 件

Crystals. (NTP, 1992)

Solid

物理化学的性質

融点
87 · 87-88℃
沸点
170 °C · 170 °C(Press: 0.04 Torr)
比重(密度)
1.185 · 1.185
屈折率
1.6 · 1.6000 (estimate)
酸解離定数(Pka)
7.45 · pKa 7.45 (Uncertain)
EPAの化学物質情報
Methdilazine (1982-37-2)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

危険有害性情報

DOT LabelPoison
Fire HazardsFlash point data for this compound are not available. It is probably combustible. (NTP, 1992)
Health HazardsSYMPTOMS: Symptoms of exposure to this compound may include drowsiness, hypotension, tachycardia, dryness of the mouth, nausea, nasal congestion, fever and tremors. (NTP, 1992)
Reactive GroupAmines, Phosphines, and Pyridines
Reactivity ProfileMETHDILAZINE is sensitive to light. (NTP, 1992).
Air and Water ReactionsNo rapid reaction with air. No rapid reaction with water.

安全と保護具

Fire FightingFires involving this material should be controlled using a dry chemical carbon dioxide or Halon extinguisher. (NTP, 1992)
First Aid · 1 件

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. If symptoms (such as redness or irritation) develop, immediately transport the victim to a hospital.

Nonfire Spill Response · 1 件

SMALL SPILLS AND LEAKAGE: If you spill this chemical, FIRST REMOVE ALL SOURCES OF IGNITION, then dampen the solid spill material with toluene, then transfer the dampened material to a suitable container. Use absorbent paper dampened with toluene to pick up any remaining material. Your contaminated clothing and absorbent paper should be sealed in a vapor-tight plastic bag for eventual disposal. Solvent-wash all contaminated surfaces with toluene followed by washing with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

化学と産業

薬理情報

ATC Code · 2 件

R - Respiratory system

QR - Respiratory system

Pharmacodynamics · 1 件

In allergic reactions an allergen interacts with and cross-links surface IgE antibodies on mast cells and basophils. Once the mast cell-antibody-antigen complex is formed, a complex series of events occurs that eventually leads to cell-degranulation and the release of histamine (and other chemical mediators) from the mast cell or basophil. Once released, histamine can react with local or widespread tissues through histamine receptors. Histamine, acting on H<sub>1</sub>-receptors, produces pruritis, vasodilatation, hypotension, flushing, headache, tachycardia, and bronchoconstriction. Histamine also increases vascular permeability and potentiates pain. Methdilazine is a histamine H<sub>1</sub> antagonist. It competes with histamine for the normal H<sub>1</sub>-receptor sites on effector cells of the gastrointestinal tract, blood vessels and respiratory tract. It provides effective, temporary relief of sneezing, watery and itchy eyes, and runny nose due to hay fever and other upper respiratory allergies.

Mechanism of ActionMethdilazine binds to the histamine H<sub>1</sub> receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine.
Absorption, Distribution and ExcretionWell absorbed in the digestive tract.
Cellular LocationsMembrane
Metabolite PathwaysMethdilazine H1-Antihistamine Action

用途と製造

UsesUsed for the symptomatic relief of hypersensitivity reactions and particularly for the control of pruritic skin disorders

応用分野

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
UNII
4Q13LY9Z8X
EC Number
217-841-6
Nikkaji
J7.838G
Isolation and EvacuationExcerpt from ERG Guide 154 [Substances - Toxic and/or Corrosive (Non-Combustible)]:
Personal Protective Equipment (PPE) · 1 件

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)

毒性情報

Exposure RoutesWell absorbed in the digestive tract.
Toxicity SummaryMethdilazine binds to the histamine H<sub>1</sub> receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine.
Signs and Symptoms · 1 件

Symptoms of overdose include clumsiness or unsteadiness, convulsions, drowsiness, dryness of mouth, nose, or throat, feeling faint, flushing or redness of face, hallucinations, muscle spasms (especially of neck and back), restlessness, shortness of breath or troubled breathing, shuffling walk, tic-like movements of head and face, trembling and shaking of hands, and trouble in sleeping.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

使用Antipruritic.

一般的な説明Crystals.

上流・下流製品情報

上流原料

塩酸フェノチアジン

サプライヤー8 社

北京华美互利生物化工010-56205725 · [email protected]
杭州摩库生物医药科技有限公司+86-057181025280; +8617767106207 · [email protected]
Chongqing jooe co., ltd+86-15223382610 · [email protected]
青岛海智微元生物科技有限公司18317699790 18317699790 · [email protected]
深圳振强药物研发有限公司+86-0755-66853366 +86-13670046396 · [email protected]
陕西缔都医药化工有限公司029-029-81120477 17792793610 · [email protected]
Shaanxi Didu New Materials Co. Ltd+86-86-17392712779 +86-13289823923 · [email protected]
重庆卡兰医药有限公司[email protected]